Wustrow D J, Wise L D, Cody D M, MacKenzie R G, Georgic L M, Pugsley T A, Heffner T G
Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, Michigan 48105.
J Med Chem. 1994 Nov 25;37(24):4251-7. doi: 10.1021/jm00050a022.
Analogs of dopamine D2 agonist 11 were prepared in which a rigid trans decalin ring system was used to mimic various conformations of 11. The four rigid analogs where compared for their ability to bind to the DA D2 receptor and to inhibit forskolin-stimulated cAMP formation, a measure of DA agonist activity. Of the four rigid analogs of compound 11, only compound 12b had significant activity in both assays. Molecular modeling studies of 12a-d showed each had a single conformation with regard to the distance between the benzamide aryl-centroid and the 4-nitrogen atom of the pyridylpiperazine. Compound 12b was shown to have a greater distance between these functionalities (11.8 A) as compared to the other isomers (9.8-10.4 A). The distance between these two functionalities in 12b was similar to that of a conformer of 11 which has an extended conformation. This suggest that 11 is likely in an extended conformation when bound to the DA D2 receptor.
